{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:48:25Z","timestamp":1696312105393},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093400","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T23:15:16Z","timestamp":1396480516000},"page":"e93400","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Charita M.","family":"Christou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hadjisavvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kyratzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Flouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Neophytou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Anastasiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Loizidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriacos","family":"Kyriacou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004320000140","article-title":"BRCA1 and BRCA2\u2014breast cancer susceptibility genes","volume":"126","author":"W Hofmann","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","article-title":"Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family","volume":"8","author":"DG Evans","year":"2008","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"D Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample","volume":"24","author":"S Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"A Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"JM Hall","year":"1990","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/382678a0","article-title":"Transcriptional activation by BRCA1","volume":"382","author":"MS Chapman","year":"1996","journal-title":"Nature"},{"key":"ref8","first-page":"3168","article-title":"BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner","volume":"56","author":"Y Chen","year":"1996","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1073\/pnas.93.24.13595","article-title":"Evidence for a transcriptional activation function of BRCA1 C-terminal region","volume":"93","author":"AN Monteiro","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"ME Moynahan","year":"1999","journal-title":"Mol Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","article-title":"Association of BRCA1 with Rad51 in mitotic and meiotic cells","volume":"88","author":"R Scully","year":"1997","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng1296-430","article-title":"Identification of a RING protein that can interact in vivo with the BRCA1 gene product","volume":"14","author":"LC Wu","year":"1996","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"TS Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","article-title":"BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications","volume":"22","author":"AW Kurian","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/378100","article-title":"A full-likelihood method for the evaluation of causality of sequence variants from family data","volume":"73","author":"D Thompson","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/10906570260199375","article-title":"Characterization of common BRCA1 and BRCA2 variants","volume":"6","author":"AM Deffenbaugh","year":"2002","journal-title":"Genet Test"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1200\/JCO.2005.07.013","article-title":"Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation","volume":"23","author":"EB Gomez-Garcia","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ijc.10337","article-title":"Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer","volume":"99","author":"A Osorio","year":"2002","journal-title":"Int J Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1158\/0008-5472.CAN-03-3009","article-title":"Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition","volume":"64","author":"N Mirkovic","year":"2004","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","article-title":"Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation","volume":"41","author":"V Abkevich","year":"2004","journal-title":"J Med Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"SV Tavtigian","year":"2006","journal-title":"J Med Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","article-title":"Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2","volume":"75","author":"DE Goldgar","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","article-title":"Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance","volume":"66","author":"G Chenevix-Trench","year":"2006","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/humu.20470","article-title":"Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information","volume":"28","author":"A Osorio","year":"2007","journal-title":"Hum Mutat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","article-title":"A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes","volume":"81","author":"DF Easton","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1200\/JCO.2007.13.2779","article-title":"Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis\u2014a report from the kConFab Investigators","volume":"26","author":"AB Spurdle","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/humu.20897","article-title":"Genetic evidence and integration of various data sources for classifying uncertain variants into a single model","volume":"29","author":"DE Goldgar","year":"2008","journal-title":"Hum Mutat"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr2223","article-title":"A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history","volume":"11","author":"EB Gomez Garcia","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1200\/JCO.2008.17.8228","article-title":"Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance","volume":"26","author":"AD Spearman","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/humu.22150","article-title":"A guide for functional analysis of BRCA1 variants of uncertain significance","volume":"33","author":"GA Millot","year":"2012","journal-title":"Hum Mutat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/hmg\/ddi476","article-title":"Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility","volume":"15","author":"JR Morris","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-06-3297","article-title":"Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis","volume":"67","author":"MA Carvalho","year":"2007","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2004.024711","article-title":"Classification of BRCA1 missense variants of unknown clinical significance","volume":"42","author":"CM Phelan","year":"2005","journal-title":"J Med Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/10.4.353","article-title":"Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families","volume":"10","author":"J Vallon-Christersson","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yexcr.2003.09.027","article-title":"Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain","volume":"293","author":"JA Rodriguez","year":"2004","journal-title":"Exp Cell Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32863","DOI":"10.1074\/jbc.271.51.32863","article-title":"The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor","volume":"271","author":"CF Chen","year":"1996","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","article-title":"Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays","volume":"70","author":"MS Lee","year":"2010","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nsmb776","article-title":"Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1","volume":"11","author":"RS Williams","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.081068398","article-title":"Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity","volume":"98","author":"H Ruffner","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1097-2765(00)80238-5","article-title":"Genetic analysis of BRCA1 function in a defined tumor cell line","volume":"4","author":"R Scully","year":"1999","journal-title":"Mol Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1158\/0008-5472.CAN-09-2850","article-title":"Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination","volume":"70","author":"DJ Ransburgh","year":"2010","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI39836","article-title":"Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations","volume":"119","author":"S Chang","year":"2009","journal-title":"J Clin Invest"},{"key":"ref43","first-page":"3237","article-title":"Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier","volume":"58","author":"GE Tomlinson","year":"1998","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.1136","article-title":"The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript","volume":"17","author":"A Vega","year":"2001","journal-title":"Hum Mutat"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm.1719","article-title":"Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2","volume":"14","author":"SG Kuznetsov","year":"2008","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/1471-2407-10-447","article-title":"An investigation of breast cancer risk factors in Cyprus: a case control study","volume":"10","author":"A Hadjisavvas","year":"2010","journal-title":"BMC Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1074\/jbc.273.14.7795","article-title":"The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain","volume":"273","author":"PS Brzovic","year":"1998","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation","volume":"276","author":"R Hashizume","year":"2001","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/ddh095","article-title":"BRCA1: BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair","volume":"13","author":"JR Morris","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Lindor NM, Guidugli L, Wang X, Vallee MP, Monteiro AN, <etal>et al<\/etal>.. (2011) A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Hum Mutat.","DOI":"10.1002\/humu.21627"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1074\/jbc.274.9.5659","article-title":"Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1","volume":"274","author":"JE Meza","year":"1999","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"38589","DOI":"10.1074\/jbc.M003851200","article-title":"Identification of a functional nuclear export sequence in BRCA1","volume":"275","author":"JA Rodriguez","year":"2000","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"21854","DOI":"10.1074\/jbc.M502676200","article-title":"An amino-terminal motif functions as a second nuclear export sequence in BRCA1","volume":"280","author":"ME Thompson","year":"2005","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"21315","DOI":"10.1074\/jbc.M200769200","article-title":"BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export","volume":"277","author":"M Fabbro","year":"2002","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1093\/emboj\/cdf691","article-title":"Activation of the E3 ligase function of the BRCA1\/BARD1 complex by polyubiquitin chains","volume":"21","author":"DL Mallery","year":"2002","journal-title":"EMBO J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1074\/jbc.M204591200","article-title":"Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein","volume":"278","author":"Y Xia","year":"2003","journal-title":"J Biol Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nature08593","article-title":"The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress","volume":"462","author":"JR Morris","year":"2009","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccr.2011.11.014","article-title":"BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance","volume":"20","author":"R Drost","year":"2011","journal-title":"Cancer Cell"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1073\/pnas.0836054100","article-title":"Binding and recognition in the assembly of an active BRCA1\/BARD1 ubiquitin-ligase complex","volume":"100","author":"PS Brzovic","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1209909","article-title":"BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity","volume":"334","author":"R Shakya","year":"2011","journal-title":"Science"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-synonymous SNPs: server and survey","volume":"30","author":"V Ramensky","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","article-title":"BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk","volume":"49","author":"AB Spurdle","year":"2012","journal-title":"J Med Genet"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nsb1001-833","article-title":"Structure of a BRCA1-BARD1 heterodimeric RING-RING complex","volume":"8","author":"PS Brzovic","year":"2001","journal-title":"Nat Struct Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:05:39Z","timestamp":1565327139000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093400"}},"subtitle":[],"editor":[{"given":"Alvaro","family":"Galli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093400","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}